Related Experiment Video
Updated: Feb 22, 2026
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
[Microvesicles derived from mesenchymal stem cells: new hope of the treatment for ARDS]
Qihong Chen1, Ruiqiang Zheng, Hualing Wang
1Department of Critical Care Medicine, Subei People' Hospital, Yangzhou 225001, Jiangsu, China (Chen QH, Zheng RQ); Department of Cardiology, Subei People' Hospital, Yangzhou 225001, Jiangsu, China (Wang HL). Corresponding author: Wang Hualing,
Objective:
Acute respiratory distress syndrome (ARDS) is a serious state threaten human health with a high mortality about 30%-40%. At present, there is no effective treatment for ARDS. Microvesicles derived from mesenchymal stem cells (MSC-MVs) have a heterogeneous subcellular structure secreted by MSCs. It plays an important role in the repair of tissue and organ damage. Recent studies have shown that MSC-MVs, played an important role in repairing lung injury, may replace MSC for cell therapy. Therefore MSC-MVs may bring new hope for ARDS treatment.
